Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Share-based Compensation (2019 - 2025)

Bioadaptives' Share-based Compensation history spans 5 years, with the latest figure at $105000.0 for Q3 2025.

  • For Q3 2025, Share-based Compensation changed N/A year-over-year to $105000.0; the TTM value through Sep 2025 reached $547541.0, changed N/A, while the annual FY2024 figure was $208871.0, N/A changed from the prior year.
  • Share-based Compensation for Q3 2025 was $105000.0 at Bioadaptives, down from $143670.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $208871.0 in Q4 2024 and bottomed at $90000.0 in Q1 2025.
  • The 3-year median for Share-based Compensation is $143670.0 (2025), against an average of $142288.2.
  • The largest YoY upside for Share-based Compensation was 1496.84% in 2021 against a maximum downside of 1496.84% in 2021.
  • A 3-year view of Share-based Compensation shows it stood at $163900.0 in 2021, then increased by 27.44% to $208871.0 in 2024, then crashed by 49.73% to $105000.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Share-based Compensation are $105000.0 (Q3 2025), $143670.0 (Q2 2025), and $90000.0 (Q1 2025).